Atropos Health
Total Raised
$50.33MInvestors Count
13Deal Terms
1Funding, Valuation & Revenue
6 Fundings
Atropos Health has raised $50.33M over 6 rounds.
Atropos Health's latest funding round was a Series B for $33M on May 23, 2024.
Atropos Health's latest post-money valuation is from May 2024.
Sign up for a free demo to see Atropos Health's valuations in May 2024 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
5/23/2024 | Series B | $33M | 4 | |||
8/10/2023 | Series A - II | |||||
8/4/2022 | Series A | |||||
12/10/2020 | Seed | |||||
12/10/2020 | Incubator/Accelerator |
Date | 5/23/2024 | 8/10/2023 | 8/4/2022 | 12/10/2020 | 12/10/2020 |
|---|---|---|---|---|---|
Round | Series B | Series A - II | Series A | Seed | Incubator/Accelerator |
Amount | $33M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 4 |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Atropos Health Deal Terms
1 Deal Term
Atropos Health's deal structure is available for 1 funding round, including their Series B from May 23, 2024.
Round | Series B |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B |
Atropos Health Investors
13 Investors
Atropos Health has 13 investors. Breyer Capital invested in Atropos Health's Series B funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/4/2022 | 5/23/2024 | 3 Series A, Series A - II (2023), Series B (2024) | Venture Capital | Texas | ||
8/10/2023 | 5/23/2024 | 2 Series A - II, Series B (2024) | Corporate Venture | California | ||
8/4/2022 | 5/23/2024 | 2 Series A, Series B (2024) | Family Office | California | ||
Corporate Venture | Pennsylvania | |||||
Venture Capital | Pennsylvania |
First funding | 8/4/2022 | 8/10/2023 | 8/4/2022 | ||
|---|---|---|---|---|---|
Last Funding | 5/23/2024 | 5/23/2024 | 5/23/2024 | ||
Investor | |||||
Rounds | 3 Series A, Series A - II (2023), Series B (2024) | 2 Series A - II, Series B (2024) | 2 Series A, Series B (2024) | ||
Board Seats | |||||
Type | Venture Capital | Corporate Venture | Family Office | Corporate Venture | Venture Capital |
Location | Texas | California | California | Pennsylvania | Pennsylvania |
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare Atropos Health to Competitors
Komodo Health specializes in healthcare analytics and operates within the healthcare technology sector. The company offers a platform that provides insights by analyzing a range of healthcare data, aiming to improve patient care and reduce disease burden. Komodo Health primarily serves life sciences companies, healthcare practitioners, payers, and patient advocacy groups with its suite of software applications designed to deliver value in healthcare through data-driven insights. It was founded in 2014 and is based in San Francisco, California.
Holmusk is a data analytics and health technology company focused on behavioral health. The company offers a real-world evidence platform that leverages AI-powered analytics and digital solutions to improve research and care in behavioral health. Holmusk's main services include providing access to a comprehensive behavioral health database, advanced data analytics software, and an electronic health records platform designed for psychiatry practices. It was founded in 2015 and is based in New York, New York.
Evidation focuses on harnessing real-world health data to measure and improve health outcomes. The company offers a digital health measurement and engagement platform that utilizes data science and machine learning to provide health guidance, treatments, and tools. Evidation primarily serves life sciences companies, government bodies, and academic institutions. It was founded in 2012 and is based in San Mateo, California.
Datavant operates as a company focused on health data connectivity in the healthcare industry. It offers services that securely and compliantly connect patient-level health data, providing solutions for data and analytics, life sciences, providers, government agencies, research networks, and health plans. Its primary customers are organizations within the healthcare sector. The company was founded in 2017 and is based in San Francisco, California.
Verantos is a company that focuses on generating high-validity real-world evidence in the life sciences sector. The company offers a platform that integrates various real-world data sources and uses artificial intelligence to generate evidence with high accuracy, completeness, and traceability. This evidence is used to accelerate clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives across all therapeutic areas. It was founded in 2015 and is based in Menlo Park, California.
Decode Health specializes in providing an AI platform as a service (PaaS) that focuses on precision medicine within the healthcare sector. The company offers solutions for pharmaceutical, diagnostic, and technology companies by leveraging multiomics, clinical data, social determinants of health, and other healthcare data sources to deliver actionable insights and accelerate research and development. Decode Health primarily serves the pharmaceutical industry, diagnostic research, and technology platforms seeking to enhance disease management and outcomes. It was founded in 2019 and is based in Nashville, Tennessee.
Loading...